- Details
- Description
Packaging Size:
10 tablets/strip; confirm with supplier
Strength:
400 mg
Composition:
Imatinib Mesylate equivalent to Imatinib 400 mg
Treatment:
Targeted anticancer therapy used for Philadelphia chromosome-positive CML, certain Ph+ ALL, gastrointestinal stromal tumors (GIST), and other specific cancers/disorders.
Form:
Tablet
Brand:
Imaxen
Quantity Unit:
Box/Tablet
Manufacturer:
Everest Pharmaceuticals Ltd.
Imaxen 400 mg Tablet (Imatinib Mesylate) is an oral anticancer medicine containing imatinib 400 mg. It is a targeted tyrosine kinase inhibitor used primarily in the treatment of Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML), certain acute lymphoblastic leukemias (Ph+ ALL), and gastrointestinal stromal tumors (GIST), among other approved conditions.
Imaxen 400 mg is a prescription anticancer tablet containing imatinib mesylate, a targeted kinase inhibitor used to treat certain blood cancers and solid tumors by blocking abnormal tyrosine kinase activity.
